KRAS and cancer: More so, our study opens a new window of opportunity to improve responses to KRAS inhibition by understanding whether and how the cancer cell-educated fibroblasts contribute to support tolerance and resistance to KRAS inhibition and how we can therapeutically explore this potential vulnerability.